Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) HKSE
16.57
-0.53(-3.10%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
16.57
-0.53(-3.10%)
Currency In HKD
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
40557
First IPO Date
October 30, 2012
| Name | Title | Pay | Year Born |
| Yi Liu | President, CEO, Co-Chair of the Innov Drugs, Chair, CEO of the Diag & Therap Tech & Exec Director | 0 | 1975 |
| Wang Xingli | Co-President & CEO of the Innovative Drugs Business Unit | 0 | 1962 |
| Wenjie Zhang | Co-President & Co-CEO of Innovative Medicines Division | 0 | 1967 |
| Jing Li | Co-President and Chief Executive Officer of Established Medicines Manufacturing & Supply Division | 0 | 1972 |
| Deyong Wen | Executive Vice Chairman | 9.71M | 1971 |
| Yue Zhu | Vice President & GM of Legal Department | 0 | 1977 |
| Yuqing Chen | Executive Chairman | 0 | 1975 |
| Zhanyu Chen | Senior Vice President & Chief Financial Officer | 0 | 1972 |
| Rongli Feng | Executive President & Chief Human Resources Officer | 0 | 1975 |
| Donghua Wang | Senior Vice President | 0 | 1969 |
| Kexin Wang | Executive Director | 0 | 1965 |
| Xiaohui Guan | Executive Co-Chairman | 0 | 1971 |
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.